Browsing Tag
London Stock Exchange
142 posts
WH Smith PLC (SMWH) suspends dividend as Middle East conflict clouds summer outlook and profit slumps to £3m in H1 2026
WH Smith PLC (SMWH) H1 2026: Revenue rises 5% to £748m but profit slumps to £3m, dividend suspended. Full-year outlook cautious. Read our analysis.
SBRY shares drop 5% on results day despite J Sainsbury plc delivering food volume gains and free cash flow ahead of target
J Sainsbury FY2026: £30bn retail sales, 6th year of volume outperformance, £300m buyback, but wide profit guidance sends SBRY down 5%. Full analysis.
ASOS Plc confirms FY26 guidance as AEBITDA surges 51% — but ASC stock sits near 52-week lows
ASOS Plc reports 51% AEBITDA growth in H1 FY26 with gross margin at a three-year high and first new customer growth since 2021. FY26 guidance confirmed. Read the full analysis.
hVIVO (AIM: HVO) wins world-first Phase III whooping cough challenge trial contract with ILiAD Biotechnologies
hVIVO (AIM: HVO) signs its largest human challenge trial contract with ILiAD Biotechnologies for a world-first pivotal Phase III pertussis vaccine study. Read what it means for investors.
GB Group plc (LSE: GBG) says FY26 was in line, so why does the update still matter for investors?
GB Group plc says FY26 was in line as growth accelerated in H2. Read what GBG’s platform push, buybacks, and FY27 outlook could mean next.
AVCT stock near 52-week high as Avacta Group pre|CISION data challenges Enhertu benchmark at AACR 2026
Avacta Group (AIM: AVCT) AACR 2026 data show AVA6103 outperforms Enhertu on tumor selectivity while AVA6207 delivers first in vivo dual payload results. Read our analysis.
Fermi (NASDAQ: FRMI) just said no to a sale, but is that confidence or a very expensive gamble?
Fermi Inc. says selling now would hurt Project Matador’s momentum. Read what the FRMI board’s stand means for strategy, risk, and shareholders.
Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Bally’s takeover talks for evoke plc could reshape UK betting. Read what the deal may mean for William Hill, debt risk, and sector consolidation.
Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?
Fresnillo (LSE: FRES) posted record $2.80bn EBITDA in 2025 but trimmed 2026 silver and gold guidance. Retail investor roadmap to the stock's next catalyst.
Antofagasta (LSE: ANTO) surges 5% as Q1 output beats consensus and Centinela build holds schedule
Antofagasta (LSE: ANTO) rose 5% after Q1 2026 production beat consensus. Here's what the Centinela concentrator build means for retail investors. 158 chars.